Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 7.57% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Poor long term growth as Net Sales has grown by an annual rate of 7.57% over the last 5 years
3
The company declared very negative results in Mar'25 after flat results in Dec'24
4
With ROCE of 5.32%, it has a expensive valuation with a 0.74 Enterprise value to Capital Employed
5
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.73%
0%
-7.73%
6 Months
-3.08%
0%
-3.08%
1 Year
1.02%
0%
1.02%
2 Years
3.83%
0%
3.83%
3 Years
-17.08%
0%
-17.08%
4 Years
-26.75%
0%
-26.75%
5 Years
-4.94%
0%
-4.94%
EnBio Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.57%
EBIT Growth (5y)
4.69%
EBIT to Interest (avg)
7.79
Debt to EBITDA (avg)
4.71
Net Debt to Equity (avg)
0.74
Sales to Capital Employed (avg)
0.53
Tax Ratio
40.15%
Dividend Payout Ratio
16.10%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.45%
ROE (avg)
8.87%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
0.55
EV to EBIT
13.98
EV to EBITDA
8.80
EV to Capital Employed
0.74
EV to Sales
1.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.32%
ROE (Latest)
4.37%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
2,438.00
2,476.50
-1.55%
Operating Profit (PBDIT) excl Other Income
246.00
151.60
62.27%
Interest
45.00
40.30
11.66%
Exceptional Items
0.00
5.20
-100.00%
Consolidate Net Profit
6.00
-137.80
104.35%
Operating Profit Margin (Excl OI)
48.40%
4.80%
4.36%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -1.55% vs 10.96% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 104.35% vs -192.48% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
10,668.10
9,575.50
11.41%
Operating Profit (PBDIT) excl Other Income
1,346.10
1,254.70
7.28%
Interest
141.30
114.70
23.19%
Exceptional Items
17.20
189.30
-90.91%
Consolidate Net Profit
420.20
739.70
-43.19%
Operating Profit Margin (Excl OI)
79.50%
85.20%
-0.57%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 11.41% vs 17.92% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -43.19% vs -6.97% in Mar 2024
About EnBio Holdings, Inc. 
EnBio Holdings, Inc.
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available






